Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us?
- 1 November 2002
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 165 (1) , 1-3
- https://doi.org/10.1016/s0021-9150(02)00191-0
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery DiseaseCirculation, 2000
- Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B VitaminsCirculation, 1998
- Reduction of Plasma Homocyst(e)ine Levels by Breakfast Cereal Fortified with Folic Acid in Patients with Coronary Heart DiseaseNew England Journal of Medicine, 1998
- Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trialsBMJ, 1998
- Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention TrialArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action ProjectPublished by American Medical Association (AMA) ,1997
- A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakesPublished by American Medical Association (AMA) ,1995
- Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based studyAtherosclerosis, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Folic acid—an innocuous means to reduce plasma homocysteineScandinavian Journal of Clinical and Laboratory Investigation, 1988